Agilent Technologies

Global Ultrasonic Nebulizer Market to Reach US$ 325.6 Million by 2030, Rising at a CAGR of 5.9% | Report by CoherentMI

Retrieved on: 
Tuesday, January 16, 2024

Among the end users, hospitals and clinics are expected to dominate the global ultrasonic nebulizer market.

Key Points: 
  • Among the end users, hospitals and clinics are expected to dominate the global ultrasonic nebulizer market.
  • Key players operating in the global ultrasonic nebulizer market include Philips Healthcare, Omron, PARI Medical, BD, and Agilent Technologies, among others.
  • Large-volume ultrasonic nebulizers are expected to dominate the global ultrasonic nebulizer market in terms of product type.
  • Overall, the global ultrasonic nebulizer market offers lucrative opportunities in large-volume nebulizers for COPD treatment and the growing demand for home healthcare solutions.

Global Ultrasonic Nebulizer Market to Reach US$ 325.6 Million by 2030, Rising at a CAGR of 5.9% | Report by CoherentMI

Retrieved on: 
Tuesday, January 16, 2024

Among the end users, hospitals and clinics are expected to dominate the global ultrasonic nebulizer market.

Key Points: 
  • Among the end users, hospitals and clinics are expected to dominate the global ultrasonic nebulizer market.
  • Key players operating in the global ultrasonic nebulizer market include Philips Healthcare, Omron, PARI Medical, BD, and Agilent Technologies, among others.
  • Large-volume ultrasonic nebulizers are expected to dominate the global ultrasonic nebulizer market in terms of product type.
  • Overall, the global ultrasonic nebulizer market offers lucrative opportunities in large-volume nebulizers for COPD treatment and the growing demand for home healthcare solutions.

Analytical Laboratory Instruments Manufacturing Global Markets 2023-2028 with Profiles of Leading Players Thermo Fisher Scientific, Agilent Technologies, Shimadzu, Danhar, Mettler-Toledo & Bruker - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 10, 2024

The "Analytical Laboratory Instruments Manufacturing: Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Analytical Laboratory Instruments Manufacturing: Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global market for analytical laboratory instruments was valued at $57.4 billion in 2022.
  • The report also features a separate section highlighting the sustainability perspective of the analytical laboratory instruments market at the global level.
  • In-depth analysis of global market trends, featuring historical revenue data for 2022, estimated figures for 2023, as well as forecasts for 2024 and 2026.

Agilent Named to Dow Jones Sustainability Indices for Ninth Consecutive Year

Retrieved on: 
Friday, January 5, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240105195532/en/
    “It’s an honor to be named in the Dow Jones Sustainability Indices for a ninth consecutive year.
  • Only 3,500 of the largest companies globally are eligible for inclusion in any Dow Jones Sustainability Index (DJSI), according to S&P Global.
  • The S&P CSA scored Agilent “ very high ” on sustainability performance, far above the industry average in all three categories.
  • Agilent is named in both the Dow Jones Sustainability World Index and the Dow Jones Sustainability North America Index .

EF Hutton Appoints David Sans as Head of Healthcare

Retrieved on: 
Wednesday, January 3, 2024

NEW YORK, NY, Jan. 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- EF Hutton, an investment bank headquartered in New York, today announced the appointment of David Sans, PhD, FAARM MBA, as Managing Director, Head of Healthcare, to lead the Company’s Healthcare & Life Sciences Investment Banking Team.

Key Points: 
  • NEW YORK, NY, Jan. 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- EF Hutton, an investment bank headquartered in New York, today announced the appointment of David Sans, PhD, FAARM MBA, as Managing Director, Head of Healthcare, to lead the Company’s Healthcare & Life Sciences Investment Banking Team.
  • David Sans, PhD, FAARM MBA, brings many years of biotech and pharma experience in corporate finance, business development, operational, and commercial roles spanning both large pharmaceutical and emerging biotechnology companies.
  • “We continue to see innovation and opportunity across the healthcare continuum in biotechnology, medical devices, healthcare IT, healthcare services, and therapeutics, and are privileged to have someone of David’s caliber serve as Head of Healthcare,” said Joseph T. Rallo, Chief Executive Officer of EF Hutton.
  • He will oversee all healthcare transactions at EF Hutton, spearheading and driving a wide range of industry transactions.

Agilent to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Monday, December 18, 2023

Agilent Technologies Inc. (NYSE: A) today announced that CEO Mike McMullen and CFO Bob McMahon will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 9, 2024, at 9:45 a.m. Pacific Time.

Key Points: 

Agilent Technologies Inc. (NYSE: A) today announced that CEO Mike McMullen and CFO Bob McMahon will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 9, 2024, at 9:45 a.m. Pacific Time.

Agilent Again Named “Global Lighthouse” by World Economic Forum for Manufacturing Innovations

Retrieved on: 
Thursday, December 14, 2023

Agilent Technologies Inc. (NYSE: A) today announced the company’s manufacturing facility in Waldbronn, Germany, has been named a Global Lighthouse by the World Economic Forum (WEF) for innovations that boost productivity, output, and quality.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced the company’s manufacturing facility in Waldbronn, Germany, has been named a Global Lighthouse by the World Economic Forum (WEF) for innovations that boost productivity, output, and quality.
  • Only 153 manufacturing facilities worldwide have received the Lighthouse distinction from WEF, and Agilent is the sole analytical and clinical laboratory technology company among them.
  • It is the second Agilent facility to be named a Lighthouse, after Agilent’s Singapore site in 2022 .
  • To earn the Lighthouse designation, the Agilent team rapidly developed, piloted, and scaled smart manufacturing technologies while navigating a period of unprecedented demand and supply chain disruption.

Agilent Resolve Raman Receives Multiple Recognitions for HazMat and CBRN Excellence

Retrieved on: 
Thursday, December 7, 2023

Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Resolve Handheld Raman Spectrometer has been recognized for excellence as a tool for emergency responders following independent use and evaluation by both the UK’s National CBRN Centre, and the US’ Department of Homeland Security.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Resolve Handheld Raman Spectrometer has been recognized for excellence as a tool for emergency responders following independent use and evaluation by both the UK’s National CBRN Centre, and the US’ Department of Homeland Security.
  • In the United Kingdom, the Resolve instrument received the National CBRN (Chemical, Biological, Radiological and Nuclear) Centre Certificate of Merit for 2023.
  • The CBRN Certificate of Merit award recognizes the value of the Resolve instrument, and the added services and responsivity Agilent provides to its customers.
  • This certificate is confirmation that all these services based in the UK recognize the benefits of the Agilent Resolve Handheld Raman Spectrometer.

Ribbon Biolabs Appoints Jodi Barrientos Chief Executive Officer; Founder Harold De Vladar Named an Advisor and Board Member

Retrieved on: 
Wednesday, December 6, 2023

Ribbon Biolabs GmbH, the DNA synthesis company, announced today that its Board of Directors had appointed Jodi Barrientos as interim Chief Executive Officer.

Key Points: 
  • Ribbon Biolabs GmbH, the DNA synthesis company, announced today that its Board of Directors had appointed Jodi Barrientos as interim Chief Executive Officer.
  • Ms. Barrientos, who joined the company this year as Chief Business Officer, brings substantial market experience to Ribbon Biolabs, as it moves forward with its commercialization plan.
  • Founder and former CEO Harold de Vladar, Ph.D., will serve as a senior advisor to the company and member of the Board.
  • Said Roopom Banerjee, Managing Partner of Whiteleaf Advisors, and Executive Chairman of the Board at Ribbon Biolabs, “We are so excited that Ribbon Biolabs has reached an inflection point under Harold’s leadership where commercial leadership is critical to the continued growth of the company.

Agilent BioTek Cytation C10 Confocal Imaging Reader Enhanced with Innovative Water Immersion Technology

Retrieved on: 
Monday, December 4, 2023

Agilent Technologies Inc. (NYSE: A) today announced the addition of water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader .

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced the addition of water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader .
  • In light microscopy, water immersion technology automatically and consistently places a layer of water between the objective lens and the sample.
  • Spinning disk confocal technology improves microscopic images by blocking out-of-focus light from reaching the image sensor.
  • Additionally, integrating it with the Agilent BioTek BioSpa 8 automated incubator enables efficient multi-plate live-cell analysis.